Overview
Dr. Armstrong works primarily in the area of women's malignancies, with a particular emphasis on breast cancer, ovarian cancer and other gynecologic malignancies, and the genetics of breast and ovarian cancer. She directs the medical gynecologic oncology clinical service and oversees therapeutic clinical trials in gynecologic cancers. Dr. Armstrong's clinical focus is on the development of new therapeutic approaches to the treatment of breast cancer and gynecologic malignancies. Particular areas of interest are intraperitoneal therapy in ovarian cancer and targeted biologic therapies. Dr. Armstrong also directs the Kimmel Cancer Center's Breast and Ovarian Cancer Screening Service, a genetic counseling service that focuses on identifying patients at risk for cancer and examination of new strategies for cancer screening and prevention. Dr. Armstrong has lectured locally, nationally and internationally. She is active in the Gynecologic Oncology Group, serving on the Medical Oncology, Developmental Therapeutics and Phase I GOG committees and as chair of several clinical trials through this group. She is a representative of the Southwest Oncology Group to the Gynecologic Cancer Steering Committee of the National Cancer Institute. Dr. Armstrong also serves as a representative of Johns Hopkins to the National Cooperative Cancer Network serving on the ovarian cancer and breast cancer risk reduction panels. She has participated as a member of the Cancer Working Group for the Office of Research on Women's Health for the National Institutes of Health, as a scientific reviewer for the breast and ovarian cancer research programs of the Department of Defense and the National Cancer Institute, as a reviewer for the NCI Special Emphasis Panel for Insight Awards to Stamp Out Breast Cancer and as a member of the NCI SPORE Program parent committee. Dr. Armstrong also is co-principal investigator for the NCI National Clinical Trials Network (NCTN) Lead Academic Participating Site (LAPS) at Johns Hopkins, now the major avenue for adult oncology clinical trials in the country. Recent work includes immune checkpoint inhibitor therapy in endometrial cancers with microsatellite instability and PARP inhibition in ovarian cancer.
Dr. Armstrong is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Testicular Yolk Sac Tumor, and Virilizing Ovarian Tumor.
Dr. Armstrong is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 1 peer reviewed article.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10803 Falls Road, Pavilion III STE 1500, Pavilion III STE 1500, Lutherville, MD 21093
201 North Broadway Street, Viragh BLDG 10th FL, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Nirmish Singla is an Oncologist practicing medicine in Lutherville, Maryland. Dr. Singla is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Singla is board certified in American Board Of Urology.
Office
Taofeek Owonikoko is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.
Skip Viragh Outpatient Cancer Center
Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, and Brain Tumor. Dr. Holdhoff is board certified in American Board Of Internal Medicine.
Frequently Asked Questions about Dr. Deborah K. Armstrong
How do I make an appointment with Dr. Deborah K. Armstrong?
You can book an appointment with Dr. Deborah K. Armstrong by calling their office at 410-583-2970. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Deborah K. Armstrong a top-rated expert for Ovarian Carcinosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Deborah K. Armstrong is classified as an Distinguished expert for Ovarian Carcinosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Deborah K. Armstrong specialize in?
While Dr. Deborah K. Armstrong is a Oncology, they have specific expertise in Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, and Testicular Yolk Sac Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Deborah K. Armstrong participate in research or clinical trials?
Yes. Dr. Deborah K. Armstrong has published 1 articles and abstracts on conditions like Ovarian Carcinosarcoma. You can view a list of Dr. Deborah K. Armstrong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Deborah K. Armstrong accept my insurance?
Dr. Deborah K. Armstrong accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-583-2970 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Ovarian CancerDr. Armstrong isDistinguished. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Armstrong isDistinguished. Learn about Ovarian Carcinosarcoma.
- Sertoli-Leydig Cell TumorDr. Armstrong isDistinguished. Learn about Sertoli-Leydig Cell Tumor.
- Testicular Yolk Sac TumorDr. Armstrong isDistinguished. Learn about Testicular Yolk Sac Tumor.
- Virilizing Ovarian TumorDr. Armstrong isDistinguished. Learn about Virilizing Ovarian Tumor.
- Advanced
- AngiosarcomaDr. Armstrong isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Armstrong isAdvanced. Learn about Breast Cancer.
- Desmoplastic Small Round Cell TumorDr. Armstrong isAdvanced. Learn about Desmoplastic Small Round Cell Tumor.
- Malignant Mixed Mullerian TumorDr. Armstrong isAdvanced. Learn about Malignant Mixed Mullerian Tumor.
- Paget Disease of the BreastDr. Armstrong isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Adult Soft Tissue SarcomaDr. Armstrong isExperienced. Learn about Adult Soft Tissue Sarcoma.
- BRCA Positive Breast CancerDr. Armstrong isExperienced. Learn about BRCA Positive Breast Cancer.
- Cervical CancerDr. Armstrong isExperienced. Learn about Cervical Cancer.
- DICER1 SyndromeDr. Armstrong isExperienced. Learn about DICER1 Syndrome.
- Endometrial CancerDr. Armstrong isExperienced. Learn about Endometrial Cancer.
- HER2 Negative Breast CancerDr. Armstrong isExperienced. Learn about HER2 Negative Breast Cancer.